Elevated memory T‐cell conversion in a preclinical mouse model of hemophilia A
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350807 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Vakhtang Kalandadze und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, Disease Models, Animal, Memory T Cells. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Fondazione Telethon, European Union's Horizon 2020 Hemacure, Fondazione Cariplo.
Abstract (Originalsprache)
One of the major challenges in the choice of the best therapeutic approach for the treatment of patients affected by hemophilia A (HA) is the definition of criteria predicting the formation of factor VIII (FVIII) neutralizing antibodies, called inhibitors. Both genetic and environmental elements influencing the immune response toward FVIII have been identified but still not all the factors causing the pathological rejection of FVIII have been identified. Since there is a connection between coagulation and inflammation, here we assessed the role played by the FVIII deficiency in shaping the humoral and cellular response toward an antigen other than FVIII itself. To this aim, we challenged both HA and wild‐type (WT) mice with either FVIII or ovalbumin (OVA) and followed antigen‐specific antibody level, immune cell population frequency and phenotype up to 9 weeks after the last antigen booster. The activation threshold was evaluated in vitro by stimulating the murine T cells with a decreasing dose of α‐CD3. The humoral response to FVIII was similar between the two groups while both the in vivo and in vitro experiments highlighted an antigen‐independent sensitivity of HA compared with WT T cells causing an increase in memory T‐cell conversion and proliferation capability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
ORCID-Profile: Vakhtang Kalandadze, Chiara Borsotti
Förderung
- Fondazione Telethon
- European Union's Horizon 2020 Hemacure
- Fondazione Cariplo
Zitieren
APA
Kalandadze, V., Di Simone, P. E., Mohammed, I., Murari, D., Follenzi, A., & Borsotti, C. (2024). Elevated memory T‐cell conversion in a preclinical mouse model of hemophilia A. European Journal of Immunology. https://doi.org/10.1002/eji.202350807
Vancouver
Kalandadze V, Di Simone PE, Mohammed I, Murari D, Follenzi A, Borsotti C. Elevated memory T‐cell conversion in a preclinical mouse model of hemophilia A. European Journal of Immunology. 2024. doi:10.1002/eji.202350807
BibTeX
@article{Kalandadze2024,
author = {Kalandadze, Vakhtang and Di Simone, Paolo E and Mohammed, Imtiyazuddin and Murari, Daniele and Follenzi, Antonia and Borsotti, Chiara},
title = {Elevated memory T‐cell conversion in a preclinical mouse model of hemophilia A},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350807}
}
EUVIMED